In the last trading session, 1.74 million shares of the Precigen Inc (NASDAQ:PGEN) were traded, and its beta was 1.85. Most recently the company’s share price was $1.7, and it changed around $0.11 or 6.92% from the last close, which brings the market valuation of the company to $501.81M. PGEN currently trades at a discount to its 52-week high of $2.17, offering almost -27.65% off that amount. The share price’s 52-week low was $0.65, which indicates that the current value has risen by an impressive 61.76% since then. We note from Precigen Inc’s average daily trading volume that its 10-day average is 2.09 million shares, with the 3-month average coming to 1.67 million.
Precigen Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended PGEN as a Hold, whereas 1 deemed it a Buy, and 1 rated it as Underweight.
Precigen Inc (NASDAQ:PGEN) trade information
Instantly PGEN has showed a green trend with a performance of 6.92% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.7100 on recent trading dayincreased the stock’s daily price by 0.58%. The company’s shares are currently up 15.65% year-to-date, but still up 19.72% over the last five days. On the other hand, Precigen Inc (NASDAQ:PGEN) is 27.82% up in the 30-day period. We can see from the shorts that 27.28 million shares have been sold at a short interest cover period of 15.46 day(s).
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 71.67% from its current value. Analyst projections state that PGEN is forecast to be at a low of $6 and a high of $6.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 25.76%.
PGEN Dividends
Precigen Inc’s next quarterly earnings report is expected to be released on 2025-May-14.
Precigen Inc (NASDAQ:PGEN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 10.52% of Precigen Inc shares, and 67.05% of them are in the hands of institutional investors. The stock currently has a share float of 74.93%. Precigen Inc stock is held by 181.0 institutions, with PATIENT CAPITAL MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 7.2017% of the shares, which is about 18.17 million shares worth $28.72 million.
BLACKROCK INC., with 4.0604% or 10.25 million shares worth $16.19 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Advisor Managed Portfolios-Patient Opportunity Trust and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 13.6 shares worth $23.12 million, making up 4.61% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 5.45 shares worth around $9.27 million, which represents about 1.85% of the total shares outstanding.
